K Pharma has raised a total of 1.55 billion yen through a third-party allotment of new shares

K Pharma has raised a total of 1.55 billion yen through a third-party allotment of new shares to the five companies, Daiwa Japan-Taiwan BioVenture No.2 Investment Limited Partnership, which is operated and managed by DCI Partners Co., Ltd., Technology Ventures No.5 Investment Limited Partnership, which is operated and managed by ITOCHU Technology Ventures Inc., Kagoshima Value Up Investment Limited Partnership, which is operated and managed by Kagoshima Development Corporation, KII No.2 Investment Limited Partnership, which is operated and managed by Keio Innovation Initiative, Inc., and ICMG Co-Creation Fund No.1 Investment Limited Partnership, which is operated and managed by ICMG Partners Co., Ltd..